TABLE 2.
Baseline values and changes in Hb concentration in children who received placebo, SP+AS+PQ, or SP+AS
| Parameter | Placebo group | SP+AS+PQ group | SP+AS group |
|---|---|---|---|
| n | 116 | 564 | 23 |
| Age (yr) (median [IQR]) | 4 (2-6.5) | 5 (3-8) | 3 (2-4) |
| Gender (% male [no. of males/total no. of individuals]) | 47.4 (55/116) | 54.8 (309/564) | 56.5 (13/23) |
| Hb concn at enrolment (g/dl) (median [IQR]) | 11.3 (9.9-12.3) | 11.7 (10.4-12.8) | 6.7 (6.2-7.3) |
| Mean difference in Hb concn on day 7 vs that on day 0 (g/dl) (95% CI) | −0.05 (−0.28-+0.18) | −0.58 (−0.46-−0.71)a | +0.62 (+0.10-+1.13)b |
a
P < 0.0001.
b
P = 0.02.